MIPS Home MIPS General Information MIPS Grants MIPS Courses MIPS Research MIPS Software MIPS Web Tools MIPS Sitemap
About MIPS MIPS News Faculty & Staff Recent Pubs Directions Facilities Events & Meetings Employment Associated Depts Useful Links
Grant News CCNE-TR CVIS ICMIC ICBP NTROI SMIS
BIOE222 Pharmacokinetics Stats & Data Analysis
BIOE222A F2009 BIOE222B W2009 BIOE222A F2008 BIOE222B W2008 BIOE222A F2007 BIOE222B W2007 BIOE222 F2006 BIOE222 F2005 BIOE222 F2004
Biswal Lab Blankenberg Lab Cheng Lab Contag Lab Felsher Lab Gambhir Lab Graves Lab Guccione Lab Levin Lab Lin Lab McConnell Moseley Lab Paik Lab Plevritis Lab Ramasamy Lab Rao Lab Rutt Lab Schnitzer Lab Vasanawala Lab Willmann Lab Wu Lab Xing Lab
NCIL MRSRL
AMIDE
NucMed Mediabook PET Brain Atlas PET-FDG Whole Body Atlas




CCNE Home

Nanobiotechnology Seminar

Annual Symposium

CCNE News

Faculty

Postdocs
Graduate Students

Scientific Papers

Corporate Collaboration

Private Foundations

Projects

Core Resources

Pilot Projects

Leadership & Organization

Environment

Links

Employment Opportunities


Center for Cancer Nanotechnology Excellence Focused on Therapy Response

Faculty

Xiaoyuan (Shawn) Chen, Ph.D.
Co-Investigator: Project 5
Assistant Professor in Radiology
Molecular Imaging Program at Stanford (MIPS)
Stanford University Radiology
Phone: (650) 725-0950
Fax: (650) 736-7925
Email: shawchen@stanford.edu


Investigator: Project 6, Acting Assistant Professor in Radiology - Nuclear Medicine (Stanford)
Dr. Chen is an Assistant Professor in Radiology focused on molecular imaging probe development and targeted drug delivery. He brings to the CCNE-TR team his expertise in radiochemistry and his research on the chemistry/radiochemistry of fundamental molecular probe design. Dr. Chen has validated a class of new RGD peptide probes that are tumor angiogenesis and metastasis specific. The probes he is developing for microPET imaging of brain tumor angiogenesis in pre-clinical animal models, along with his models to test angiogenesis inhibitors, can be translated into a clinical setting for improved patient management. He was also currently funded by NIBIB and DOD to develop near-infrared fluorescence imaging probes (both fluorescent dye and quantum dot based) for tumor imaging in vivo.

[ Back ]
crumpnews events